Ildong Holdings Co Ltd Total Liabilities
Ildong Holdings Co Ltd total liabilities. Based on the latest financial reports, Ildong Holdings Co Ltd (000230) has total liabilities worth ₩434.34 Billion KRW (≈ $294.35 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Ildong Holdings Co Ltd (000230) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Ildong Holdings Co Ltd (1999–2025)
Total liabilities of Ildong Holdings Co Ltd from 1999 to 2025. This chart illustrates how Ildong Holdings Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Ildong Holdings Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Ildong Holdings Co Ltd Competitors by Total Liabilities
The table below lists competitors of Ildong Holdings Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MACH7 Technologies Ltd
AU:M7T
|
Australia | AU$18.63 Million |
|
Metal Sky Star Acquisition Corporation Ordinary shares
NASDAQ:MSSA
|
USA | $8.21 Million |
|
K Seng Seng Corporation Bhd
KLSE:5192
|
Malaysia | RM160.49 Million |
|
Green Cross Medical Science Corporation
KQ:142280
|
Korea | ₩40.86 Billion |
|
Intellicheck Mobilisa Inc
NASDAQ:IDN
|
USA | $3.08 Million |
|
Eversendai Corporation Bhd
KLSE:5205
|
Malaysia | RM2.28 Billion |
|
PBG S.A
SA:PTBL3
|
Brazil | R$3.37 Billion |
|
CVC Technologies
TWO:4744
|
Taiwan | NT$841.42 Million |
Liability Composition Analysis (1999–2025)
This chart breaks down Ildong Holdings Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Ildong Holdings Co Ltd asset portfolio.
Liquidity & Leverage Metrics
Ildong Holdings Co Ltd Total Liabilities Ratios Explained
Ildong Holdings Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ildong Holdings Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ildong Holdings Co Ltd (1999–2025)
The table below shows the annual total liabilities of Ildong Holdings Co Ltd from 1999 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩457.28 Billion ≈ $309.89 Million |
-23.88% |
| 2024-12-31 | ₩600.70 Billion ≈ $407.09 Million |
-15.05% |
| 2023-12-31 | ₩707.10 Billion ≈ $479.19 Million |
+1.97% |
| 2022-12-31 | ₩693.45 Billion ≈ $469.94 Million |
-5.96% |
| 2021-12-31 | ₩737.42 Billion ≈ $499.74 Million |
+49.34% |
| 2020-12-31 | ₩493.79 Billion ≈ $334.63 Million |
+1.91% |
| 2019-12-31 | ₩484.53 Billion ≈ $328.36 Million |
+382.01% |
| 2018-12-31 | ₩100.52 Billion ≈ $68.12 Million |
+0.32% |
| 2017-12-31 | ₩100.20 Billion ≈ $67.91 Million |
+3.04% |
| 2016-12-31 | ₩97.25 Billion ≈ $65.90 Million |
-72.66% |
| 2015-12-31 | ₩355.66 Billion ≈ $241.02 Million |
+23.75% |
| 2014-12-31 | ₩287.40 Billion ≈ $194.76 Million |
-4.71% |
| 2013-12-31 | ₩301.61 Billion ≈ $204.40 Million |
+38.80% |
| 2012-12-31 | ₩217.30 Billion ≈ $147.26 Million |
+7.85% |
| 2011-12-31 | ₩201.48 Billion ≈ $136.54 Million |
-14.71% |
| 2010-12-31 | ₩236.23 Billion ≈ $160.09 Million |
+9.74% |
| 2009-12-31 | ₩215.26 Billion ≈ $145.88 Million |
+8.76% |
| 2008-12-31 | ₩197.93 Billion ≈ $134.13 Million |
+41.10% |
| 2007-12-31 | ₩140.28 Billion ≈ $95.06 Million |
+26.62% |
| 2006-12-31 | ₩110.78 Billion ≈ $75.08 Million |
-0.45% |
| 2005-12-31 | ₩111.29 Billion ≈ $75.42 Million |
+3.78% |
| 2004-12-31 | ₩107.23 Billion ≈ $72.67 Million |
-5.20% |
| 2003-12-31 | ₩113.11 Billion ≈ $76.65 Million |
+11.93% |
| 2002-12-31 | ₩101.06 Billion ≈ $68.49 Million |
-2.59% |
| 2001-12-31 | ₩103.74 Billion ≈ $70.31 Million |
-14.10% |
| 2000-12-31 | ₩120.77 Billion ≈ $81.84 Million |
-9.20% |
| 1999-12-31 | ₩133.00 Billion ≈ $90.13 Million |
-- |
About Ildong Holdings Co Ltd
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the… Read more